![]()
32
| 1 | 2008
Klinisk Biokemi i Norden
(Fortsætter side 34)
(Fortsat fra side 31)
ated with warfarin dose. Pharmacogenomics J
2005;5:262-70.
18. Bustin SA, Mueller R. Real-time reverse tran-
scription PCR (qRT-PCR) and its potential
use in clinical diagnosis. Clin Sci (Lond)
2005;109:365-79.
19. ZebischA, LinkeschW, Sill H. Bedside RNA sta-
bilizing kit systems for gene expression analysis
of acute leukemias: influence of non-neoplastic
white blood cells. Leukemia 2005;19:685.
20. DePrimo SE, Wong LM, Khatry DB, Nicholas
SL, Manning WC, Smolich BD et al. Expression
profiling of blood samples from an SU5416
Phase III metastatic colorectal cancer clinical
trial: a novel strategy for biomarker identifica-
tion. BMC Cancer 2003;3:3.
21. Zieglschmid V, Hollmann C, Bocher O.
Detection of disseminated tumor cells
in peripheral blood. Crit Rev Clin Lab Sci
2005;42:155-96.
22. Ma J, Liew CC. Gene profiling identifies secret-
ed protein transcripts from peripheral blood
cells in coronary artery disease. J Mol Cell
Cardiol 2003;35:993-8.
23. Feezor RJ, Baker HV, Mindrinos M, Hayden
D, Tannahill CL, Brownstein BH et al. Whole
blood and leukocyte RNA isolation for
gene expression analyses. Physiol Genomics
2004;19:247-54.
24. Whitney AR, Diehn M, Popper SJ, Alizadeh
AA, Boldrick JC, Relman DA, Brown PO.
Individuality and variation in gene expression
patterns in human blood. Proc Natl Acad Sci U
S A 2003;100:1896-901.
25. Pahl A. Gene expression profiling using RNA
extracted from whole blood: technologies and
clinical applications. Expert Rev Mol Diagn
2005;5:43-52.
26. Fan H, Hegde PS. The transcriptome in blood:
challenges and solutions for robust expression
profiling. Curr Mol Med 2005;5:3-10.
27. Imbeaud S, Graudens E, Boulanger V, Barlet X,
Zaborski P, Eveno E et al. Towards standardiza-
tion of RNA quality assessment using user-inde-
pendent classifiers of microcapillary electro-
phoresis traces. Nucleic Acids Res 2005;33:e56.
28. Schutten M, Niesters HG. Clinical utility of
viral quantification as a tool for disease moni-
toring. Expert Rev Mol Diagn 2001;1:153-62.
29. Mulder J, McKinney N, Christopherson C,
Sninsky J, Greenfield L, Kwok S. Rapid and
simple PCR assay for quantitation of human
immunodeficiency virus type 1 RNA in plas-
ma: application to acute retroviral infection. J
Clin Microbiol 1994;32:292-300.
30. Sun R, Ku J, Jayakar H, Kuo JC, Brambilla
D, Herman S et al. Ultrasensitive reverse
transcription-PCR assay for quantitation of
human immunodeficiency virus type 1 RNA
in plasma. J Clin Microbiol 1998;36:2964-9.
31. Rohde G, Borg I, Arinir U, Bufe A, Dorsten
C, Schultze-Werninghaus G, Bauer TT.
Evaluation of a real-time polymerase-chain
reaction for severe acute respiratory syndrome
(SARS) associated coronavirus in patients
with hospitalised exacerbation of COPD. Eur
J Med Res 2004;9:505-9.
32. Hochhaus A, Reiter A, Skladny H, Reichert
A, Saussele S, Hehlmann R. Molecular moni-
toring of residual disease in chronic myelog-
enous leukemia patients after therapy. Recent
Results Cancer Res 1998;144:36-45.
33. JonesCD,YeungC,ZehnderJL.Comprehensive
validation of a real-time quantitative bcr-abl
assay for clinical laboratory use. Am J Clin
Pathol 2003;120:42-8.
34. Mandel, P and Metais, P. Les acides nucleiques
du plasma sanguin chez l`homme. Acad.Sci.
Paris 142, 241-243. 1948.
35. Tong YK, Lo YM. Diagnostic developments
involving cell-free (circulating) nucleic acids.
Clin Chim Acta 2006;363:187-96.
36. Tsui NB, Ng EK, Lo YM. Stability of endog-
enous and added RNA in blood speci-
mens, serum, and plasma. Clin Chem
2002;48:1647-53.
37. Ng EK, Tsui NB, Lau TK, Leung TN, Chiu
RW, Panesar NS et al. mRNA of placental ori-
gin is readily detectable in maternal plasma.
Proc Natl Acad Sci U S A 2003;100:4748-53.
38. Laktionov PP, Tamkovich SN, Rykova EY,
Bryzgunova OE, Starikov AV, Kuznetsova NP,
